{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:01:09Z","timestamp":1774544469036,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21878022"],"award-info":[{"award-number":["21878022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673335"],"award-info":[{"award-number":["81673335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0901800"],"award-info":[{"award-number":["2018YFA0901800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bmcl.2022.128761","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:12:17Z","timestamp":1650921137000},"page":"128761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Design and synthesis of novel macrolones bridged with linkers from 11,12-positions of macrolides"],"prefix":"10.1016","volume":"68","author":[{"given":"Xie-Peng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue-Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Zhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128761_b0005","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1021\/jm980240d","article-title":"Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): A new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens","volume":"41","author":"Agouridas","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7164\/antibiotics.54.664","article-title":"Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs","volume":"54","author":"Kashimura","year":"2001","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bmcl.2022.128761_b0015","doi-asserted-by":"crossref","first-page":"17152","DOI":"10.1073\/pnas.1007988107","article-title":"Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action","volume":"107","author":"Dunkle","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bmcl.2022.128761_b0020","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1073\/pnas.1008685107","article-title":"Revisiting the structures of several antibiotics bound to the bacterial ribosome","volume":"107","author":"Bulkley","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bmcl.2022.128761_b0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/46.6.1017","article-title":"The in vitro activity of ABT773, a new ketolide antimicrobial agent","volume":"46","author":"Andrews","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"2016","key":"10.1016\/j.bmcl.2022.128761_b0030","first-page":"3662","article-title":"Results from the Solithromycin International Surveillance Program","volume":"60","author":"Farrell","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2022.128761_b0035","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/jac\/dkr161","article-title":"In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae","volume":"66","author":"Sato","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bmcl.2022.128761_b0040","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1016\/j.bmc.2016.08.035","article-title":"The solithromycin journey-It is all in the chemistry","volume":"24","author":"Fernandes","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2165\/00003088-200544090-00003","article-title":"Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial","volume":"44","author":"Shi","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bmcl.2022.128761_b0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.22620","article-title":"Telithromycin-Associated Hepatotoxicity: Clinical Spectrum and Causality Assessment of 42 Cases","volume":"49","author":"Brinker","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bmcl.2022.128761_b0055","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/AAC.00840-10","article-title":"Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors","volume":"54","author":"Bertrand","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2022.128761_b0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2146\/ajhp160934","article-title":"Solithromycin: A novel ketolide antibiotic","volume":"74","author":"Buege","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.bmcl.2022.128761_b0065","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2174\/1568026620999201203213733","article-title":"Recent Advancements in Macrolide Hybrids against Staphylococcus aureus","volume":"21","author":"Ji","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0070","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1016\/j.bmc.2010.10.024","article-title":"Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials","volume":"18","author":"Pavlovic","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bmcl.2022.128761_b0080","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"Dinos","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bmcl.2022.128761_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25173941","article-title":"Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview","volume":"25","author":"Undheim","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128761_b0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bmcl.2018.11.038","article-title":"Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides","volume":"29","author":"Tevyashova","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2022.128761_b0095","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1039\/D0OB02428G","article-title":"Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications","volume":"19","author":"Yang","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112222","article-title":"Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone\/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides","volume":"193","author":"Fan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0105","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.accounts.1c00020","article-title":"Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens","volume":"54","author":"Myers","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bmcl.2022.128761_b0110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram positive pathogens","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111662","article-title":"14-and 15-membered lactone macrolides and their analogues and hybrids: structure, molecular mechanism of action and biological activity","volume":"182","author":"Janas","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0120","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.2174\/15680266113136660223","article-title":"Structure-Activity Relationships and Mechanism of Action of Macrolides Derived from Erythromycin as Antibacterial Agents","volume":"13","author":"Liang","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1568026616666160927160036","article-title":"Macrolide Hybrid Compounds: Drug Discovery Opportunities in AntiInfective and Anti-inflammatory Area","volume":"17","author":"Paljetak","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.02.073","article-title":"Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens","volume":"169","author":"Ma","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2016.09.022","article-title":"Synthesis of novel 15-membered 8a-azahomoerythromycin A acylides: Consequences of structural modification at the C-3 and C-6 position on antibacterial activity","volume":"125","author":"Pavlovic","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0140","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1016\/j.bmc.2010.06.050","article-title":"Synthesis and biological activity of 4 ''-O-acyl derivatives of 14-and 15-membered macrolides linked to omega-quinolone-carboxylic unit","volume":"18","author":"Skugor","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/ml100253p","article-title":"Discovery of 4 ''-Ether Linked Azithromycin-Quinolone Hybrid Series: Influence of the Central Linker on the Antibacterial Activity","volume":"2","author":"Pavlovic","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2022.128761_b0150","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/AAC.00524-16","article-title":"Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo","volume":"60","author":"Paljetak","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2022.128761_b0155","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00860-10","article-title":"Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis","volume":"54","author":"Llano-Sotelo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmcl.2022.128761_b0160","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.bmcl.2018.06.039","article-title":"Synthesis and antibacterial activity of novel ketolides with 11,12-quinoylalkyl side chains","volume":"28","author":"Zhao","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2022.128761_b0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/op060001x","article-title":"A facile and scaleable synthesis of 3-O-decladinose-6-methyl-10,11-dehydrate-erythromycin-3-one-2 '-acetate, an important intermediate for ketolide synthesis","volume":"10","author":"Wei","year":"2006","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.bmcl.2022.128761_b0170","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.bmcl.2010.03.038","article-title":"Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives","volume":"20","author":"Liang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2022.128761_b0175","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1016\/j.bmc.2011.07.010","article-title":"Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activity","volume":"19","author":"Kapic","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0180","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature17967","article-title":"A platform for the discovery of new macrolide antibiotics","volume":"533","author":"Seiple","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2022.128761_b0185","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/35101544","article-title":"Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria","volume":"413","author":"Schlunzen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2022.128761_b0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41589-020-00715-0","article-title":"Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance","volume":"17","author":"Svetlov","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bmcl.2022.128761_b0195","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1515\/BC.2005.141","article-title":"Species-specific antibiotic-ribosome interactions: implications for drug development","volume":"386","author":"Wilson","year":"2005","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bmcl.2022.128761_b0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2005.02.005","article-title":"Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance","volume":"121","author":"Tu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2022.128761_b0205","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/JB.185.14.4276-4279.2003","article-title":"Structural insight into the antibiotic action of telithromycin against resistant mutants","volume":"185","author":"Berisio","year":"2003","journal-title":"J. Bacteriol."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22002372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22002372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:43:54Z","timestamp":1760773434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22002372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":41,"alternative-id":["S0960894X22002372"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128761","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel macrolones bridged with linkers from 11,12-positions of macrolides","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128761"}}